Studies have reported association between the TOMM40 523 repeat and brain-related phenotypes such as risk of AD diagnosis [22], earlier/later age of AD clinical onset [3,21,22], cortisol levels [23] and cognitive change in older age [24], independent of APOE. This evidence concerns the gene APOE and Alzheimer disease.